相关实验视频
Updated: May 27, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
Enpp1通过AMPK/PPARα信号通路调节肝细胞脂质代谢来改善MAFLD
Xiaohui Liu1, Shuai Chen2, Xing Liu1
1Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences (CAMS) & Comparative Medicine Centre, Peking Union Medical College (PUMC), Beijing, 100021, China.
乙核酸铁酸/化酶1 (Enpp1) 通过调节脂质代谢来改善与代谢功能障碍相关的脂肪肝疾病 (MAFLD). Enpp1针对AMPK/PPARα通路,为MAFLD提供了一个潜在的治疗策略.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 代谢疾病 代谢疾病
- 分子生物学分子生物学
背景情况:
- 与代谢功能障碍相关的脂肪肝疾病 (MAFLD) 是一个日益严重的全球健康问题,没有批准的治疗方法.
- 乙核酸铁酸/化酶1 (Enpp1) 涉及胰岛素耐药性和脂质积累,但其在MAFLD中的作用尚不清楚.
研究的目的:
- 研究Enpp1在MAFLD发展中的作用和机制.
- 探索Enpp1作为MAFLD的潜在治疗点.
主要方法:
- 在MAFLD患者中对Enpp1表达的临床研究.
- 具有肝脏特异性Enpp1淘汰和过度表达的小鼠模型.
- 转录数据挖掘和实验验证.
- 药理上抑制AMPK活动.
主要成果:
- 在MAFLD患者的肝脏中,Enpp1的表达减少.
- 在小鼠中,Enpp1缺乏会加剧肥胖,胰岛素抵抗和肝肥胖症,而过度表达会逆转这些影响.
- 缺乏Enpp1会抑制AMPK和PPARα,促进脂质合成和MAFLD的进展.
- Enpp1通过AMP/ATP比增强AMPK活性,通过PPARα和下游脂质代谢因子进行上调.
结论:
- Enpp1通过AMPK/PPARα信号通路调节脂质代谢来改善MAFLD.
- 在MAFLD治疗中,Enpp1是一个有前途的治疗标.
更多相关视频
08:20Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model
Published on: December 2, 2022
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
相关概念视频
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
cAMP-dependent Protein Kinase Pathways
Regulation of Nuclear Protein Sorting
The Unfolded Protein Response
PI3K/mTOR/AKT Signaling Pathway
Regulation of the Unfolded Protein Response